Stockreport

Immunovant to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Immunovant, Inc.  (IMVT) 
PDF NEW YORK, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for patients w [Read more]